Cited by 355Attention Deficit Hyperactivity DisorderAutism Spectrum Disorder ResearchDevelopmental and Educational Neuropsychology

Attention-deficit/hyperactivity disorder

Open access
Faraone, Stephen V., Bellgrove, Mark A., Brikell, Isabell, Cortese, Samuele, Hartman, Catharina A., Hollis, Chris, Newcorn, Jeffrey H., Philipsen, Alexandra +4 more·2024·Nature Reviews Disease Primers

Abstract

Attention-deficit/hyperactivity disorder (ADHD; also known as hyperkinetic disorder) is a common neurodevelopmental condition that affects children and adults worldwide. ADHD has a predominantly genetic aetiology that involves common and rare genetic variants. Some environmental correlates of the disorder have been discovered but causation has been difficult to establish. The heterogeneity of the condition is evident in the diverse presentation of symptoms and levels of impairment, the numerous co-occurring mental and physical conditions, the various domains of neurocognitive impairment, and extensive minor structural and functional brain differences. The diagnosis of ADHD is reliable and valid when evaluated with standard diagnostic criteria. Curative treatments for ADHD do not exist but evidence-based treatments substantially reduce symptoms and/or functional impairment. Medications are effective for core symptoms and are usually well tolerated. Some non-pharmacological treatments are valuable, especially for improving adaptive functioning. Clinical and neurobiological research is ongoing and could lead to the creation of personalized diagnostic and therapeutic approaches for this disorder.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41572-024-00495-0

Cites

58 of 58 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Specialist visits for substance use disorders, depression, and anxiety were chosen due to their high comorbidity with ADHD, frequent exclusion from RCTs, and current clinical uncertainty regarding treatment approaches.

    “Specialist visits for substance use disorders, depression, and anxiety were chosen due to their high comorbidity with ADHD, frequent exclusion from RCTs, and current clinical uncertainty regarding treatment approaches.13”

    From Evaluating ADHD medication trial representativeness: a Swedish population-based study comparing hypothetically trial-eligible and trial-ineligible individuals (2025) · cites this paper as [13]

    The available passages are bibliographic metadata (the author listing and “5 Citations (Scopus)” section) and an “Abstract” section containing an access link, not discussion of the claim. Searches for comorbidity, substance use disorders, depression and anxiety, RCT exclusions, and treatment uncertainty found no passage addressing those points in our copy. (LLM, conf=0.75)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Faraone, S. V., Bellgrove, M. A., Brikell, I., Cortese, S., Hartman, C. A., Hollis, C., Newcorn, J. H., Philipsen, A., Polanczyk, G. V., Rubia, K., Sibley, M. H., & Buitelaar, J. K.
Affiliations
  • SUNY Upstate Medical University (US)
  • Monash University (AU)
  • Aarhus University (DK)
  • Solent NHS Trust (GB)
  • University Medical Center Groningen (NL)
  • University of Nottingham (GB)
  • Icahn School of Medicine at Mount Sinai (US)
  • University Hospital Bonn (DE)
  • Universidade de São Paulo (BR)
  • King's College London (GB)
  • University of Washington (US)
  • Radboud University Medical Center (NL)
Corresponding author
Faraone, Stephen V.
Venue
Nature Reviews Disease Primers
Published
2024-02-22
Volume
10
Issue
1
Pages
11-11
ISSN
2056-676X (ISSN-L)
OpenAlex
W4392057793
Cited by
355
References
58
Citations by year
2026: 163 · 2025: 156 · 2024: 34 · 2015: 1 · 2014: 1
FWCI
28.24
Type
journal article
Language
en
Open access
Locations
  • Nature Reviews Disease Primers (publishedVersion)
  • PubMed (publishedVersion)
  • ePrints Soton (University of Southampton) (acceptedVersion)
  • University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, other-oa)
  • Radboud Repository (Radboud University) (submittedVersion)
Funders
  • UK Research and Innovation
  • Action Medical Research
  • National Institute for Health and Care Research (NIHR203310, NIHR130077, NIHR128472, NIHR203035, MIC-2016-003, 101095568, RP-PG-0618-20003, NIHR303122, NIHR203684)
  • Department of Health and Social Care
  • King's College London (115300)
  • European Commission (101095568, 965381, 945151, HORIZON2020, 115300, 847879, 777394, 847818)
  • Deutsche Forschungsgemeinschaft
  • Fundação de Amparo à Pesquisa do Estado de São Paulo (16/22455-8)
  • ZonMw (636340003, 636340002)
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico (310582/2017-2, 2017‐2)
  • Institute of Education Sciences
  • Institute of Psychiatry, Psychology and Neuroscience, King’s College London
  • Medical Research Council (MR/T046864/1, 115300, MR/P012647/1, 777394)
  • Research Executive Agency
  • National Health and Medical Research Council (MRF2006438, 2010899, 1154378, EPCD000002)
  • National Institute of Mental Health (R34MH122225, 1R21MH1264940, R01MH116037, R34MH125037)
  • National Institute of Neurological Disorders and Stroke (R01NS128535)
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (U01AR076092)
  • National Institute of Child Health and Human Development
  • Eurostars
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
  • Social Sciences › Psychology › Neuropsychology and Physiological Psychology › Developmental and Educational Neuropsychology
Keywords
attention deficit hyperactivity disorder, hyperkinetic disorder, neurodevelopmental disorders, genetic aetiology, genetic variants, environmental risk factors, symptom heterogeneity, comorbidities, neurocognitive impairment, brain structure and function, ADHD diagnosis, diagnostic criteria, evidence-based treatment, pharmacotherapy, non-pharmacological treatment, personalized medicine
MeSH terms
Adult, Attention Deficit Disorder with Hyperactivity, Brain, Child, Humans

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review